| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Eric Lazartigues | |
| Huijing Xia | |||
| P2860 | cites work | A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase | Q22254730 |
| A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 | Q24290169 | ||
| Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation | Q24311938 | ||
| Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins | Q24321922 | ||
| Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas | Q24680069 | ||
| Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase | Q28115041 | ||
| Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus | Q28188496 | ||
| Angiotensin-converting enzyme 2 is an essential regulator of heart function | Q28205840 | ||
| Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme | Q28216431 | ||
| The Isolation of a New Hypotensive Peptide, Neurotensin, from Bovine Hypothalami | Q28245181 | ||
| A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury | Q28260798 | ||
| Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function | Q28264715 | ||
| The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases | Q28302418 | ||
| Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression | Q28583180 | ||
| Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain | Q28645999 | ||
| Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice | Q57184568 | ||
| Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat | Q57217071 | ||
| Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men | Q57315164 | ||
| Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions | Q58215379 | ||
| Interaction of bradykinin and angiotensin-(1–7) in the central modulation of the baroreflex control of the heart rate | Q62124895 | ||
| RNA interference shows interactions between mouse brainstem angiotensin AT1 receptors and angiotensin-converting enzyme 2 | Q64376766 | ||
| Area postrema is critical for angiotensin-induced hypertension in rats | Q68960911 | ||
| Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides | Q69723243 | ||
| Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme | Q70457433 | ||
| Tissue-specific regulation of angiotensinogen gene expression in spontaneously hypertensive rats | Q71104696 | ||
| The sustained antihypertensive effect of chronic cerebroventricular infusion of angiotensin antagonist in spontaneously hypertensive rats | Q71358947 | ||
| Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene | Q72204948 | ||
| Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats | Q72282326 | ||
| Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin | Q72307451 | ||
| Central blood pressure effects of substance P and angiotensin II: role of the sympathetic nervous system and vasopressin | Q72636366 | ||
| Inhibition of the renin-angiotensin system. A new approach to the therapy of hypertension | Q72903365 | ||
| Hypothesis: ACE2 modulates blood pressure in the mammalian organism | Q73167489 | ||
| Neuro-cardiovascular regulation: from molecules to man. Introduction | Q74218884 | ||
| Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio | Q79782432 | ||
| Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population | Q79843197 | ||
| Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women | Q80251093 | ||
| Neurogenic abnormalities in masked hypertension | Q80589434 | ||
| Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart | Q80935229 | ||
| Central and peripheral cardiovascular actions of apelin in conscious rats | Q81103358 | ||
| Involvement of angiotensin-(1-7) in the hypothalamic hypotensive effect of captopril in sinoaortic denervated rats | Q81239804 | ||
| Effects of intracerebroventricular infusion of angiotensin-(1-7) on bradykinin formation and the kinin receptor expression after focal cerebral ischemia-reperfusion in rats | Q81419036 | ||
| Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats | Q83967489 | ||
| Novel peptide inhibitors of angiotensin-converting enzyme 2. | Q31133376 | ||
| Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents | Q31151042 | ||
| Mass-spectrometric identification of a novel angiotensin peptide in human plasma. | Q33265175 | ||
| Identification and characterisation of the angiotensin converting enzyme-3 (ACE3) gene: a novel mammalian homologue of ACE. | Q33289135 | ||
| Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice | Q33319072 | ||
| Angiotensin peptides and inducible transcription factors | Q33544635 | ||
| Multiple organ infection and the pathogenesis of SARS. | Q33988914 | ||
| Angiotensin-(1-7): an update. | Q34019825 | ||
| Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. | Q34830604 | ||
| Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis | Q35088385 | ||
| A story of two ACEs | Q35109747 | ||
| Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system | Q35127232 | ||
| Oxidative stress through activation of NAD(P)H oxidase in hypertensive mice with spontaneous intracranial hemorrhage | Q35157673 | ||
| Physiological genomic analysis of the brain renin-angiotensin system | Q35196494 | ||
| Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system | Q35567432 | ||
| Angiotensin-(1-7): blood, heart, and blood vessels. | Q36297733 | ||
| Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. | Q36579769 | ||
| Novel mechanisms of sympathetic regulation in chronic heart failure | Q36610547 | ||
| Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy | Q36773270 | ||
| Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages | Q37122931 | ||
| Brain renin angiotensin in disease | Q37127331 | ||
| Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats | Q37247541 | ||
| Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. | Q37352071 | ||
| A decrease in angiotensin receptor binding in rat brain nuclei by antisense oligonucleotides to the angiotensin AT1 receptor. | Q38290158 | ||
| Functions of angiotensin in the central nervous system | Q39763524 | ||
| Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis | Q39993080 | ||
| The renin-angiotensin system | Q40138391 | ||
| Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis | Q40399203 | ||
| Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. | Q40510688 | ||
| Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy | Q40811095 | ||
| Differential baroreceptor reflex modulation by centrally infused angiotensin peptides | Q42462109 | ||
| Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice | Q42519083 | ||
| Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. | Q43547068 | ||
| Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors | Q44162874 | ||
| Site-specific effects of apelin-13 in the rat medulla oblongata on arterial pressure and respiration | Q44236290 | ||
| Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. | Q44353743 | ||
| Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2. | Q44592757 | ||
| Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors | Q44790566 | ||
| Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? | Q44840244 | ||
| Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats | Q45069630 | ||
| The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules | Q45092010 | ||
| Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats | Q45101312 | ||
| Myocardial infarction increases ACE2 expression in rat and humans. | Q45238600 | ||
| Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways | Q45640664 | ||
| Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. | Q46352475 | ||
| Cardiovascular effects of angiotensin II and angiotensin-(1-7) at the RVLM of trained normotensive rats | Q46416842 | ||
| Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats | Q46440284 | ||
| Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure | Q46491166 | ||
| Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. | Q46493539 | ||
| Spontaneous stroke in a genetic model of hypertension in mice | Q46508463 | ||
| Distribution of the non-AT1, non-AT2 angiotensin-binding site in the rat brain: preliminary characterization | Q46533216 | ||
| Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade | Q46581147 | ||
| Impaired heart rate baroreflex in older rats: role of endogenous angiotensin-(1-7) at the nucleus tractus solitarii | Q46595087 | ||
| Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents. | Q46662642 | ||
| Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls | Q46678604 | ||
| Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes | Q46715078 | ||
| Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors | Q46749509 | ||
| Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology | Q46771630 | ||
| Jacques Benoit lecture: the neuroendocrine view of the angiotensin and apelin systems. | Q46808752 | ||
| Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. | Q46966464 | ||
| Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis | Q47727551 | ||
| Angiotensin-converting enzyme 2 protects from severe acute lung failure | Q47768368 | ||
| Increased concentration of angiotensin II binding sites in selected brain areas of spontaneously hypertensive rats | Q48132473 | ||
| Effects of intraventricular angiotensin II mediated by the sympathetic nervous system | Q48157017 | ||
| Hypotensive function of the brain angiotensin-(1-7) in Sprague Dawley and renin transgenic rats | Q48169169 | ||
| Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. | Q48171114 | ||
| Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats | Q48260358 | ||
| Cardiovascular effects produced by micro-injection of angiotensin-(1-7) on vasopressor and vasodepressor sites of the ventrolateral medulla | Q48267625 | ||
| The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes | Q48350561 | ||
| Angiotensin II attenuates baroreflexes at nucleus tractus solitarius of rats | Q48379811 | ||
| ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. | Q48491814 | ||
| Angiotensin biosynthesis and concentrations in brain of normotensive and hypertensive rats | Q48697678 | ||
| Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril | Q48752124 | ||
| The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon | Q48833033 | ||
| Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus. | Q50511397 | ||
| Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy. | Q51718615 | ||
| Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome. | Q51820362 | ||
| Periventricular forebrain mechanisms for blood pressure regulation | Q52500330 | ||
| Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. | Q52938072 | ||
| ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. | Q53545484 | ||
| Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. | Q53595366 | ||
| Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from north-western China. | Q54590701 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 1482-1494 | |
| P577 | publication date | 2008-11-05 | |
| 2008-12-01 | |||
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Angiotensin-converting enzyme 2 in the brain: properties and future directions | |
| P478 | volume | 107 |
| Q28072451 | A Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous Systems |
| Q59794194 | A Genomic Survey of Angiotensin-Converting Enzymes Provides Novel Insights into Their Molecular Evolution in Vertebrates |
| Q35760437 | ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy |
| Q35776364 | ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension |
| Q38086829 | ACE2, angiotensin-(1–7), and Mas: the other side of the coin |
| Q40159156 | ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke |
| Q34784864 | ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. |
| Q96293058 | Acute hemorrhage after intra-cerebral biopsy in COVID-19 patients: a report of 3 cases |
| Q36152606 | An Essential role for DeltaFosB in the median preoptic nucleus in the sustained hypertensive effects of chronic intermittent hypoxia |
| Q37347019 | Angiotensin (1-7) contributes to nitric oxide tonic inhibition of vasopressin release during hemorrhagic shock in acute ethanol intoxicated rodents |
| Q28592286 | Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogen-activated protein kinase and extracellular signal-regulated kinase 1/2 signaling |
| Q37225431 | Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice |
| Q35707198 | Angiotensin II-induced hypertension is modulated by nuclear factor-κBin the paraventricular nucleus. |
| Q27022788 | Angiotensin peptides and nitric oxide in cardiovascular disease |
| Q37440125 | Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology |
| Q33572819 | Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy |
| Q34978620 | Angiotensin-converting enzyme 2: central regulator for cardiovascular function |
| Q34423315 | Angiotensin-converting enzymes and drug discovery in cardiovascular diseases. |
| Q35543326 | Augmented central nitric oxide production inhibits vasopressin release during hemorrhage in acute alcohol-intoxicated rodents |
| Q112034257 | Autoimmune Encephalitis in COVID-19 Infection: Our Experience and Systematic Review of the Literature |
| Q33639490 | Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension |
| Q99207926 | COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment |
| Q93273889 | COVID-19: A primer for Neuroradiologists |
| Q91717735 | COVID-19: Risk Groups, Mechanistic Insights, and Challenges |
| Q46894741 | Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme |
| Q35833441 | Effect of a Selective Mas Receptor Agonist in Cerebral Ischemia In Vitro and In Vivo. |
| Q89687484 | Exosome-Mediated Transfer of ACE2 (Angiotensin-Converting Enzyme 2) from Endothelial Progenitor Cells Promotes Survival and Function of Endothelial Cell |
| Q34380550 | Functional up-regulation of endopeptidase neurolysin during post-acute and early recovery phases of experimental stroke in mouse brain |
| Q36033367 | Gene transfer of angiotensin-converting enzyme 2 in the nucleus tractus solitarius improves baroreceptor heart rate reflex in spontaneously hypertensive rats |
| Q53318750 | Genetic influences on Alzheimer's disease: evidence of interactions between the genes APOE, APOC1 and ACE in a sample population from the South of Brazil. |
| Q95289623 | HOW TO DETECT AND TRACK CHRONIC NEUROLOGIC SEQUELAE OF COVID-19? USE OF AUDITORY BRAINSTEM RESPONSES AND NEUROIMAGING FOR LONG-TERM PATIENT FOLLOW-UP |
| Q97530822 | Immune-mediated approaches against COVID-19 |
| Q96289423 | Intracerebral haemorrhage (ICH) and COVID-19: Clinical characteristics from a case series |
| Q55346138 | Modulation of the expression of genes related to the system of amyloid-beta metabolism in the brain as a novel mechanism of ceftriaxone neuroprotective properties. |
| Q99552345 | Neuroinvasion of SARS-CoV-2 in human and mouse brain |
| Q94591308 | Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community |
| Q94672351 | Non-lesional status epilepticus in a patient with coronavirus disease 2019 |
| Q33913160 | Overexpression of angiotensin-converting enzyme 2 attenuates tonically active glutamatergic input to the rostral ventrolateral medulla in hypertensive rats |
| Q99629027 | Renin-angiotensin system blockers and severe acute respiratory syndrome coronavirus 2 |
| Q96948835 | Revealing the synergistic mechanism of Shenfu Decoction for anti-heart failure through network pharmacology strategy |
| Q26821967 | Review article: pancreatic renin-angiotensin systems in health and disease |
| Q49135151 | Role of angiotensin-(1-7) in rostral ventrolateral medulla in blood pressure regulation via sympathetic nerve activity in Wistar-Kyoto and spontaneous hypertensive rats |
| Q109296626 | SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation |
| Q38214892 | Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases. |
| Q94959577 | The Socially Distanced Social Animal - In The New Covid-19 Era |
| Q33677369 | Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases |
| Q98288102 | Towards Neuro-CoViD-19 |
| Q37769761 | Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters |
| Q99637658 | Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms |
| Q51762826 | Within the Brain: The Renin Angiotensin System. |
Search more.